Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Makaleler > Tam Makale · 2023
Yazarlar: Erhan GÖKMEN, Laurence Albiges, Howard Gurney, Vagif Atduev, Christina Suarez, Miguel A Climent, David Pook, Piotr Tomczak, Philippe Barthelemy, Jae Lyun Lee, Viktor Stus, Thomas Ferguson, Pawel Wiecheno, Louis Lacombe, Craig Gedye, Rodolfo Perini, Manish Sharma, Xiang Peng, Chung-Han Lee
The Lancet Oncology, SSCI İndekslerine Giren Dergi, Uluslararası, Wos, 2023, cilt 24, ss 881-891